Literature DB >> 19955180

Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary.

Su-Chin Sun1, Pei-Jen Hsu, Fang-Ju Wu, Sheng-Hsiang Li, Chung-Hao Lu, Ching-Wei Luo.   

Abstract

The thyroid-stimulating hormone receptor (TSHR), activated by either TSH or the newly discovered glycoprotein hormone thyrostimulin, plays a central role in the control of body metabolism. Interestingly, in addition to its thyroid expression, we discovered that the mRNA level of TSHR is periodically regulated in rat ovary by gonadotropins. Ovarian microdissection followed by real-time PCR analysis indicated that granulosa cells show the highest level of TSHR expression. Cultures of follicles and primary granulosa cells demonstrated that the level of TSHR is up-regulated and decreased by the gonadotropin-driven cAMP cascade and estradiol production, respectively. Furthermore, in contrast to the negligible expression of TSH in the ovary, we also found by real-time PCR and immunohistochemical analysis that thyrostimulin is expressed mainly in oocytes. Evolving before the appearance of gonadotropins, thyrostimulin is considered the most ancestral glycoprotein hormone. Therefore, the presence of thyrostimulin in the ovary suggests that it may have a primitive function in reproduction when it activates ovarian TSHR. Next, we generated recombinant thyrostimulin protein and characterized its non-covalent heterodimeric nature. Using purified recombinant thyrostimulin, we show that the human ovarian cell line NIH:OVCAR-3 also expresses endogenous and functional TSHR. Using cultured rat granulosa cells isolated from different ovarian stages, we found that treatments with thyrostimulin significantly increase cAMP production and the c-fos gene response in the presence of gonadotropins. Thus, this study demonstrates that oocyte-derived thyrostimulin and granulosa cell-expressed TSHR compose a novel paracrine system in the ovary, where the activity is tightly controlled by gonadotropins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955180      PMCID: PMC2823517          DOI: 10.1074/jbc.M109.066266

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  The thyrotropin receptor and the regulation of thyrocyte function and growth.

Authors:  G Vassart; J E Dumont
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

2.  Really old hormones up to new tricks: glycoprotein hormone subunits may have roles in development.

Authors:  Vance L Trudeau
Journal:  Endocrinology       Date:  2009-08       Impact factor: 4.736

3.  Familial isolated thyrotropin deficiency with cretinism.

Authors:  K Miyai; M Azukizawa; Y Kumahara
Journal:  N Engl J Med       Date:  1971-11-04       Impact factor: 91.245

4.  Functional thyrotropin receptor expression in the pituitary folliculo-stellate cell line TtT/GF.

Authors:  L J S Brokken; O Bakker; W M Wiersinga; M F Prummel
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-01       Impact factor: 2.949

5.  Thyrotropin receptor expression in adrenal, kidney, and thymus.

Authors:  C M Dutton; W Joba; C Spitzweg; A E Heufelder; R S Bahn
Journal:  Thyroid       Date:  1997-12       Impact factor: 6.568

6.  Resistance to diet-induced obesity in mice globally overexpressing OGH/GPB5.

Authors:  Lynn E Macdonald; Katherine E Wortley; Lori C Gowen; Keith D Anderson; Jane D Murray; William T Poueymirou; Mary V Simmons; Dianna Barber; David M Valenzuela; Aris N Economides; Stanley J Wiegand; George D Yancopoulos; Mark W Sleeman; Andrew J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

Review 7.  Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms.

Authors:  Gunnar Kleinau; Gerd Krause
Journal:  Endocr Rev       Date:  2009-01-27       Impact factor: 19.871

8.  Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors.

Authors:  Ching-Wei Luo; Kazuhiro Kawamura; Cynthia Klein; Aaron J W Hsueh
Journal:  Mol Endocrinol       Date:  2004-05-06

9.  Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

Authors:  T C Hamilton; R C Young; W M McKoy; K R Grotzinger; J A Green; E W Chu; J Whang-Peng; A M Rogan; W R Green; R F Ozols
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

10.  Synergistic transcriptional activation of the thyrotropin receptor promoter by cyclic AMP-responsive-element-binding protein and thyroid transcription factor 1.

Authors:  A Saiardi; P Falasca; D Civitareale
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

View more
  24 in total

1.  [Synthesis, metabolism and diagnostics of thyroid hormones].

Authors:  J Köhrle; G Brabant
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

2.  Distinct expression patterns of glycoprotein hormone subunits in the lophotrochozoan Aplysia: implications for the evolution of neuroendocrine systems in animals.

Authors:  Andreas Heyland; David Plachetzki; Evonne Donelly; Dinuka Gunaratne; Yelena Bobkova; John Jacobson; Andrea B Kohn; Leonid L Moroz
Journal:  Endocrinology       Date:  2012-09-13       Impact factor: 4.736

3.  Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.

Authors:  Ann-Karin Haas; Gunnar Kleinau; Inna Hoyer; Susanne Neumann; Jens Furkert; Claudia Rutz; Ralf Schülein; Marvin C Gershengorn; Gerd Krause
Journal:  Cell Mol Life Sci       Date:  2010-07-22       Impact factor: 9.261

4.  Thyrotropin receptor stimulates internalization-independent persistent phosphoinositide signaling.

Authors:  Alisa Boutin; Michael D Allen; Elizabeth Geras-Raaka; Wenwei Huang; Susanne Neumann; Marvin C Gershengorn
Journal:  Mol Pharmacol       Date:  2011-04-27       Impact factor: 4.436

5.  Malignant Clinical Course of "Proliferative" Ovarian Struma: Diagnostic Challenges and Treatment Pitfalls.

Authors:  Aleksandra Asaturova; Alina Magnaeva; Anna Tregubova; Vlada Kometova; Yevgeniy Karamurzin; Sergey Martynov; Yuliya Lipatenkova; Leila Adamyan; Andrea Palicelli
Journal:  Diagnostics (Basel)       Date:  2022-06-07

6.  A Novel Antigonadotropic Role of Thyroid Stimulating Hormone on Leydig Cell-Derived Mouse Leydig Tumor Cells-1 Line.

Authors:  Bodhana Dhole; Surabhi Gupta; Skand Shekhar; Anand Kumar
Journal:  Ann Natl Acad Med Sci       Date:  2020-01

Review 7.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

8.  Malignant Struma Ovarii with Concurrent Thyroid Cancer: Outcomes during and after Pregnancy.

Authors:  Sara Donato; Helder Simões; Valeriano Leite
Journal:  Eur Thyroid J       Date:  2021-01-27

9.  Paracrine interactions of thyroid hormones and thyroid stimulation hormone in the female reproductive tract have an impact on female fertility.

Authors:  Anneli Stavreus Evers
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-30       Impact factor: 5.555

10.  VolcanoFinder: Genomic scans for adaptive introgression.

Authors:  Derek Setter; Sylvain Mousset; Xiaoheng Cheng; Rasmus Nielsen; Michael DeGiorgio; Joachim Hermisson
Journal:  PLoS Genet       Date:  2020-06-18       Impact factor: 6.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.